Product Code: ETC8837416 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for cerebral vasospasm treatment is evolving as hospitals in the Philippines invest in therapies for patients recovering from subarachnoid hemorrhages. Treatments include pharmaceutical interventions and endovascular techniques aimed at preventing secondary brain damage caused by restricted blood flow.
The cerebral vasospasm market in the Philippines is seeing growth, driven by the increasing prevalence of subarachnoid hemorrhages and other cerebrovascular conditions. Therapeutic options to manage vasospasm, including pharmacological agents and interventions like balloon angioplasty, are in demand, with newer treatments focusing on minimizing brain damage and improving patient recovery.
The cerebral vasospasm market in the Philippines grapples with the challenge of limited access to real-time neuro-monitoring and specialized interventions required to manage this serious complication of subarachnoid hemorrhage. The availability of vasospasm-specific drugs and endovascular treatments is mostly confined to major hospitals. Financial barriers and lack of insurance coverage further limit patients` access to optimal care.
The cerebral vasospasm market in the Philippines offers significant growth opportunities, particularly in the treatment of subarachnoid hemorrhage, which can lead to vasospasma condition where the blood vessels in the brain constrict. As the incidence of traumatic brain injuries and stroke rises, there is an increasing need for effective treatment options to prevent or reverse cerebral vasospasm. Investors can take advantage of this market by developing innovative therapies and devices that can effectively address the vasospasm issue, improving patient outcomes and enhancing the quality of care.
In the Philippines, the government has taken steps to raise awareness about cerebral vasospasm, particularly after subarachnoid hemorrhages. Medical institutions are encouraged to adopt new treatments for cerebral vasospasm, and the government promotes research and development to improve patient care in this field. Policies also focus on improving the availability of medical treatments and ensuring they are covered under public health insurance schemes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Cerebral Vasospasm Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Cerebral Vasospasm Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Cerebral Vasospasm Market - Industry Life Cycle |
3.4 Philippines Cerebral Vasospasm Market - Porter's Five Forces |
3.5 Philippines Cerebral Vasospasm Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Philippines Cerebral Vasospasm Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Cerebral Vasospasm Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Philippines Cerebral Vasospasm Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Cerebral Vasospasm Market Trends |
6 Philippines Cerebral Vasospasm Market, By Types |
6.1 Philippines Cerebral Vasospasm Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Philippines Cerebral Vasospasm Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Philippines Cerebral Vasospasm Market Revenues & Volume, By CT Scan, 2021- 2031F |
6.1.4 Philippines Cerebral Vasospasm Market Revenues & Volume, By Computed Tomography Angiography (CTA), 2021- 2031F |
6.1.5 Philippines Cerebral Vasospasm Market Revenues & Volume, By Digital Subtraction Angiography (DSA), 2021- 2031F |
6.1.6 Philippines Cerebral Vasospasm Market Revenues & Volume, By Magnetic Resonance Angiography (MRA), 2021- 2031F |
6.1.7 Philippines Cerebral Vasospasm Market Revenues & Volume, By Transcranial Doppler (TCD), 2021- 2031F |
6.2 Philippines Cerebral Vasospasm Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Cerebral Vasospasm Market Revenues & Volume, By Nimodipine, 2021- 2031F |
6.2.3 Philippines Cerebral Vasospasm Market Revenues & Volume, By Triple-H Therapy, 2021- 2031F |
6.2.4 Philippines Cerebral Vasospasm Market Revenues & Volume, By Balloon Angioplasty, 2021- 2031F |
6.2.5 Philippines Cerebral Vasospasm Market Revenues & Volume, By Vasopressors, 2021- 2031F |
6.2.6 Philippines Cerebral Vasospasm Market Revenues & Volume, By Inotropes, 2021- 2031F |
6.2.7 Philippines Cerebral Vasospasm Market Revenues & Volume, By Thrombolytic Agents, 2021- 2031F |
6.3 Philippines Cerebral Vasospasm Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Philippines Cerebral Vasospasm Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Philippines Cerebral Vasospasm Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Philippines Cerebral Vasospasm Market Revenues & Volume, By Trauma Centers, 2021- 2031F |
6.3.5 Philippines Cerebral Vasospasm Market Revenues & Volume, By Emergency Departments, 2021- 2031F |
6.3.6 Philippines Cerebral Vasospasm Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Cerebral Vasospasm Market Import-Export Trade Statistics |
7.1 Philippines Cerebral Vasospasm Market Export to Major Countries |
7.2 Philippines Cerebral Vasospasm Market Imports from Major Countries |
8 Philippines Cerebral Vasospasm Market Key Performance Indicators |
9 Philippines Cerebral Vasospasm Market - Opportunity Assessment |
9.1 Philippines Cerebral Vasospasm Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Philippines Cerebral Vasospasm Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Cerebral Vasospasm Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Philippines Cerebral Vasospasm Market - Competitive Landscape |
10.1 Philippines Cerebral Vasospasm Market Revenue Share, By Companies, 2024 |
10.2 Philippines Cerebral Vasospasm Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |